Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Oxford researchers secure funding for world's first ovarian cancer prevention vaccine

General Research

Researchers have been awarded funding from Cancer Research UK to create the world’s first vaccine to prevent ovarian cancer.

US adults in worse health than British counterparts at midlife

General Research

US adults have significantly worse health in midlife compared to their British peers, especially in markers of cardiovascular health, according to a new study involving researchers from Oxford’s Leverhulme Centre for Demographic Science, published in the International Journal of Epidemiology.

Professor Sir Aziz Sheikh OBE starts as new Head of the Nuffield Department of Primary Care Health Sciences

Awards and Appointments General

Professor Sir Aziz Sheikh takes over the role of Head of Department from Professor Richard Hobbs CBE from 1 October 2024

New GSK collaboration will develop use of biostatistics and AI in research

General Research

With a base in the University's Nuffield Department of Medicine and Department of Statistics, the collaboration will draw upon biostatistical and artificial intelligence (AI) expertise across Oxford, prioritising the development of innovative new tools and methods that translate to medical and biopharmaceutical research.

Access, prevention, and education: three key pillars to tackle antimicrobial resistance effectively

General Research

Timothy Walsh, Director of Biology at the Ineos Oxford Institute for antimicrobial research outlines three priorities that global leaders must consider at the UN High-Level Meeting on AMR held today.

Oxford Vaccine Group marks 30 years battling ‘deadly six’ diseases with major art installation

General Public Engagement with Research

A major art installation featuring dramatically upscaled bacteria, viruses and a parasite is being unveiled on 26 September at Oxford University’s Museum of Natural History to celebrate 30 years of vaccine development at the Oxford Vaccine Group (OVG) - tackling some of the world’s most deadly diseases.

New therapies developed by Oxford experts offer online support for anxiety and post-traumatic stress disorders

General Innovation

Four internet-based therapies developed by experts at the University of Oxford’s Department of Experimental Psychology and Department of Psychiatry are proving helpful for patients with social anxiety disorder and post-traumatic stress disorders and for children with anxiety disorders.

Urgent action needed to understand links between air pollution and mental health

General Research

Leading scientists are calling for urgent global action to better understand the links between air pollution and mental health.

Launch of new podcast series Trusting the Science

General Research

The Oxford Vaccine Group is celebrating 30 years of life-saving vaccine development with the release of a new podcast series of conversations called Trusting the Science. This is the second series of The Oxford Colloquy - a series of discourses hosted by Professor Sir Andrew Pollard who has been Director of the group for over 20 years - and each episode delves into the crucial role that science plays in our understanding of health and immunity.

Tim Denison elected a Fellow of the Royal Academy of Engineering

Awards and Appointments General

Many congratulations to BNDU Group Leader Professor Tim Denison on the announcement today of his election to the Fellowship of the Royal Academy of Engineering.

Researchers develop new tool to better predict AML outcomes in older patients

General Research

In a study published in the Journal of Clinical Oncology, an international research team has used machine learning to improve risk stratification for patients over 60 diagnosed with acute myeloid leukaemia, an aggressive type of blood cancer.

Antibiotic resistance has claimed at least one million lives each year since 1990: GRAM

General Research

Landmark GRAM Project study of global AMR burden over time forecasts a sharp rise in deaths, with 39 million lives lost between now and 2050

Study discovers new process for cells to repair DNA damage

General Research

A team of international researchers at the University of Oxford (Oxford) and Nanyang Technological University, Singapore (NTU Singapore), has discovered a new process for repairing damaged DNA that is particularly relevant for patients undergoing colorectal cancer treatments.

Study increases understanding of lung microbiome in severe asthma patients

General Research

Respiratory researchers in Oxford have discovered a link between potentially pathogenic bacteria and airways inflammation in severe asthma.

Impact of social factors on suicide must be recognised

General Research

The impact of social factors such as poverty and abuse on suicide need to be recognised and action taken to address them, according to a major series of papers published in the Lancet Public Health on World Suicide Prevention Day.

Oxford receives funding to develop a cancer prevention vaccine for Lynch syndrome

General Research

Cancer Research UK funds University of Oxford scientists to develop ‘LynchVax’, the UK’s first vaccine aiming to prevent cancer in people with Lynch syndrome who have a much higher risk of developing several types of cancer.

Robust memory of a previous event shown to prevent new flexible memories from being formed

General Research

Researchers at the Medical Research Council Brain (MRC) Network Dynamics Unit in Oxford's Nuffield Department of Clinical Neurosciences have discovered a new neuronal mechanism in the hippocampus, that prevents new ‘flexible’ memories from being formed due to a past ‘robust’ memory.

Professor Sarah Harper announced as new chair of HelpAge International Board of Trustees

Awards and Appointments General

HelpAge International has appointed Sarah Harper, Clore Professor of Gerontology at the University of Oxford and founder of Oxford’s Institute of Population Ageing, as the new Chair of the Board of Trustees.

Load More